Biocon informs about updates

18 Feb 2025 Evaluate
Biocon has informed that it enclosed the company statement titled ‘European Commission Approves Biocon Biologics’ Ustekinumab Biosimilar’. The above information will also be available on the website of the Company at www.biocon.com.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

380.05 -3.50 (-0.91%)
10-Dec-2025 15:47 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1789.45
Dr. Reddys Lab 1249.70
Cipla 1489.15
Zydus Lifesciences 919.00
Lupin 2054.55
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×